Takeda to sell Dunboyne plant

The shock news that Takeda, the company that bought Shire last year is planning to sell its new facility at Dunboyne has led to calls on the IDA and the government to launch a special task force to find a new buyer .

Employees at the multi million euro facility were told this morning of the company's plans to sell the Dunboyne facility and local politicians were also informed of the move.

In a letter seen by the Meath Chronicle, Susan Hynes, site lead at the Dunboyne plant, said that Takeda plans to divest the facility as a going concern, with no redundancies intended for the employees on site.

"A strategic review of Takeda’s global biologics manufacturing network, initiated following the acquisition of Shire, identified that production capacity at Dunboyne is no longer required. Takeda has commenced the process of seeking the most suitable buyer and is confident in the successful divestiture of the facility. Dunboyne Biologics is a state-of-the-art, flexible manufacturing facility with leading-edge capability, a highly educated and skilled team, which will be an attractive asset for a future buyer."

Dunboyne's Cllr Damien O'Reilly has called for the creation of a task force to urgently launch an action plan.